Higher rates of allergies, autoimmune diseases and low-grade inflammation markers in treatment-resistant major depression
Open Access
- 30 July 2021
- journal article
- research article
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 16, 100313
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: A [11C]PBR28 PET studyBrain, Behavior, and Immunity, 2013
- Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regressionJournal of Affective Disorders, 2012
- Pollen‐specific immunoglobulin E positivity is associated with worsening of depression scores in bipolar disorder patients during high pollen seasonBipolar Disorders, 2012
- Association between Depression and C-Reactive ProteinCardiology Research and Practice, 2011
- Major Depression and Coronary Artery Disease in the Swedish Twin RegistryArchives of General Psychiatry, 2009
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-AnalysisPsychosomatic Medicine, 2009
- Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart DiseaseJAMA, 2008
- Changes in Allergy Symptoms and Depression Scores Are Positively Correlated In Patients With Recurrent Mood Disorders Exposed to Seasonal Peaks in AeroallergensThe Scientific World Journal, 2007
- Twelve-Month Use of Mental Health Services in the United StatesArchives of General Psychiatry, 2005
- Cytokine Production and Treatment Response in Major Depressive DisorderNeuropsychopharmacology, 2000